The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023
Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that...
Gespeichert in:
| Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 2023-08, Vol.195 (31), p.E1030 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 31 |
| container_start_page | E1030 |
| container_title | Canadian Medical Association journal (CMAJ) |
| container_volume | 195 |
| creator | Murphy, Tanya J Swail, Hanna Jain, Jaspreet Anderson, Maureen Awadalla, Philip Behl, Lesley Brown, Patrick E Charlton, Carmen L Colwill, Karen Drews, Steven J Gingras, Anne-Claude Hinshaw, Deena Jha, Prabhat Kanji, Jamil N Kirsh, Victoria A Lang, Amanda L.S Langlois, Marc-Andre Lee, Stephen Lewin, Antoine O'Brien, Sheila F Pambrun, Chantale Skead, Kimberly Stephens, David A Stein, Derek R Tipples, Graham Van Caeseele, Paul G Evans, Timothy G Oxlade, Olivia Mazer, Bruce D Buckeridge, David L |
| description | Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity. |
| doi_str_mv | 10.1503/cmaj.230949 |
| format | Article |
| fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A760576387</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A760576387</galeid><sourcerecordid>A760576387</sourcerecordid><originalsourceid>FETCH-LOGICAL-g2007-52523e805f8478f230f512acb34880c6f5ac882edce4b64e0ad17e23eff94cf03</originalsourceid><addsrcrecordid>eNqVzl1LwzAUBuAgCs7plX8g6JVgZpr0I_VuFD8GQ2Gb3pYsPakZbTqbdui_N6AXG_TGHEggPOecF6HLgE6CiPI7VcvNhHGahukRGgWhEIRxlh6jERWMEp6G8Sk6c25D_eEsGaHV6gMw7Jqq70xjcaPxcrpYkqx5Jww7aJttCztZgVWAjcWZtLKQ91jiztRAPDDgsOv64vsWM-p3-IufoxMtKwcXf-8YvT0-rLJnMn99mmXTOSkZpQmJWMQ4CBppESZC-9w6CphUa-6DUxXrSCohGBQKwnUcApVFkIBv0ToNlaZ8jK5_55Y-YW6sbrpWqto4lU-TmEZJzEXiFRlQJVhoZdVY0MZ_H_irAa-25jPfR5MB5KuA2qjBqTcHDd508NWVsncuny0X_7Av-_YHC9CUmA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Murphy, Tanya J ; Swail, Hanna ; Jain, Jaspreet ; Anderson, Maureen ; Awadalla, Philip ; Behl, Lesley ; Brown, Patrick E ; Charlton, Carmen L ; Colwill, Karen ; Drews, Steven J ; Gingras, Anne-Claude ; Hinshaw, Deena ; Jha, Prabhat ; Kanji, Jamil N ; Kirsh, Victoria A ; Lang, Amanda L.S ; Langlois, Marc-Andre ; Lee, Stephen ; Lewin, Antoine ; O'Brien, Sheila F ; Pambrun, Chantale ; Skead, Kimberly ; Stephens, David A ; Stein, Derek R ; Tipples, Graham ; Van Caeseele, Paul G ; Evans, Timothy G ; Oxlade, Olivia ; Mazer, Bruce D ; Buckeridge, David L</creator><creatorcontrib>Murphy, Tanya J ; Swail, Hanna ; Jain, Jaspreet ; Anderson, Maureen ; Awadalla, Philip ; Behl, Lesley ; Brown, Patrick E ; Charlton, Carmen L ; Colwill, Karen ; Drews, Steven J ; Gingras, Anne-Claude ; Hinshaw, Deena ; Jha, Prabhat ; Kanji, Jamil N ; Kirsh, Victoria A ; Lang, Amanda L.S ; Langlois, Marc-Andre ; Lee, Stephen ; Lewin, Antoine ; O'Brien, Sheila F ; Pambrun, Chantale ; Skead, Kimberly ; Stephens, David A ; Stein, Derek R ; Tipples, Graham ; Van Caeseele, Paul G ; Evans, Timothy G ; Oxlade, Olivia ; Mazer, Bruce D ; Buckeridge, David L</creatorcontrib><description>Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.</description><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>DOI: 10.1503/cmaj.230949</identifier><language>eng</language><publisher>CMA Impact Inc</publisher><subject>Canada ; Epidemics ; Risk factors ; Statistics</subject><ispartof>Canadian Medical Association journal (CMAJ), 2023-08, Vol.195 (31), p.E1030</ispartof><rights>COPYRIGHT 2023 CMA Impact Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27901,27902</link.rule.ids></links><search><creatorcontrib>Murphy, Tanya J</creatorcontrib><creatorcontrib>Swail, Hanna</creatorcontrib><creatorcontrib>Jain, Jaspreet</creatorcontrib><creatorcontrib>Anderson, Maureen</creatorcontrib><creatorcontrib>Awadalla, Philip</creatorcontrib><creatorcontrib>Behl, Lesley</creatorcontrib><creatorcontrib>Brown, Patrick E</creatorcontrib><creatorcontrib>Charlton, Carmen L</creatorcontrib><creatorcontrib>Colwill, Karen</creatorcontrib><creatorcontrib>Drews, Steven J</creatorcontrib><creatorcontrib>Gingras, Anne-Claude</creatorcontrib><creatorcontrib>Hinshaw, Deena</creatorcontrib><creatorcontrib>Jha, Prabhat</creatorcontrib><creatorcontrib>Kanji, Jamil N</creatorcontrib><creatorcontrib>Kirsh, Victoria A</creatorcontrib><creatorcontrib>Lang, Amanda L.S</creatorcontrib><creatorcontrib>Langlois, Marc-Andre</creatorcontrib><creatorcontrib>Lee, Stephen</creatorcontrib><creatorcontrib>Lewin, Antoine</creatorcontrib><creatorcontrib>O'Brien, Sheila F</creatorcontrib><creatorcontrib>Pambrun, Chantale</creatorcontrib><creatorcontrib>Skead, Kimberly</creatorcontrib><creatorcontrib>Stephens, David A</creatorcontrib><creatorcontrib>Stein, Derek R</creatorcontrib><creatorcontrib>Tipples, Graham</creatorcontrib><creatorcontrib>Van Caeseele, Paul G</creatorcontrib><creatorcontrib>Evans, Timothy G</creatorcontrib><creatorcontrib>Oxlade, Olivia</creatorcontrib><creatorcontrib>Mazer, Bruce D</creatorcontrib><creatorcontrib>Buckeridge, David L</creatorcontrib><title>The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023</title><title>Canadian Medical Association journal (CMAJ)</title><description>Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.</description><subject>Canada</subject><subject>Epidemics</subject><subject>Risk factors</subject><subject>Statistics</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqVzl1LwzAUBuAgCs7plX8g6JVgZpr0I_VuFD8GQ2Gb3pYsPakZbTqbdui_N6AXG_TGHEggPOecF6HLgE6CiPI7VcvNhHGahukRGgWhEIRxlh6jERWMEp6G8Sk6c25D_eEsGaHV6gMw7Jqq70xjcaPxcrpYkqx5Jww7aJttCztZgVWAjcWZtLKQ91jiztRAPDDgsOv64vsWM-p3-IufoxMtKwcXf-8YvT0-rLJnMn99mmXTOSkZpQmJWMQ4CBppESZC-9w6CphUa-6DUxXrSCohGBQKwnUcApVFkIBv0ToNlaZ8jK5_55Y-YW6sbrpWqto4lU-TmEZJzEXiFRlQJVhoZdVY0MZ_H_irAa-25jPfR5MB5KuA2qjBqTcHDd508NWVsncuny0X_7Av-_YHC9CUmA</recordid><startdate>20230814</startdate><enddate>20230814</enddate><creator>Murphy, Tanya J</creator><creator>Swail, Hanna</creator><creator>Jain, Jaspreet</creator><creator>Anderson, Maureen</creator><creator>Awadalla, Philip</creator><creator>Behl, Lesley</creator><creator>Brown, Patrick E</creator><creator>Charlton, Carmen L</creator><creator>Colwill, Karen</creator><creator>Drews, Steven J</creator><creator>Gingras, Anne-Claude</creator><creator>Hinshaw, Deena</creator><creator>Jha, Prabhat</creator><creator>Kanji, Jamil N</creator><creator>Kirsh, Victoria A</creator><creator>Lang, Amanda L.S</creator><creator>Langlois, Marc-Andre</creator><creator>Lee, Stephen</creator><creator>Lewin, Antoine</creator><creator>O'Brien, Sheila F</creator><creator>Pambrun, Chantale</creator><creator>Skead, Kimberly</creator><creator>Stephens, David A</creator><creator>Stein, Derek R</creator><creator>Tipples, Graham</creator><creator>Van Caeseele, Paul G</creator><creator>Evans, Timothy G</creator><creator>Oxlade, Olivia</creator><creator>Mazer, Bruce D</creator><creator>Buckeridge, David L</creator><general>CMA Impact Inc</general><scope>ISN</scope><scope>ISR</scope></search><sort><creationdate>20230814</creationdate><title>The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023</title><author>Murphy, Tanya J ; Swail, Hanna ; Jain, Jaspreet ; Anderson, Maureen ; Awadalla, Philip ; Behl, Lesley ; Brown, Patrick E ; Charlton, Carmen L ; Colwill, Karen ; Drews, Steven J ; Gingras, Anne-Claude ; Hinshaw, Deena ; Jha, Prabhat ; Kanji, Jamil N ; Kirsh, Victoria A ; Lang, Amanda L.S ; Langlois, Marc-Andre ; Lee, Stephen ; Lewin, Antoine ; O'Brien, Sheila F ; Pambrun, Chantale ; Skead, Kimberly ; Stephens, David A ; Stein, Derek R ; Tipples, Graham ; Van Caeseele, Paul G ; Evans, Timothy G ; Oxlade, Olivia ; Mazer, Bruce D ; Buckeridge, David L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g2007-52523e805f8478f230f512acb34880c6f5ac882edce4b64e0ad17e23eff94cf03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Canada</topic><topic>Epidemics</topic><topic>Risk factors</topic><topic>Statistics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murphy, Tanya J</creatorcontrib><creatorcontrib>Swail, Hanna</creatorcontrib><creatorcontrib>Jain, Jaspreet</creatorcontrib><creatorcontrib>Anderson, Maureen</creatorcontrib><creatorcontrib>Awadalla, Philip</creatorcontrib><creatorcontrib>Behl, Lesley</creatorcontrib><creatorcontrib>Brown, Patrick E</creatorcontrib><creatorcontrib>Charlton, Carmen L</creatorcontrib><creatorcontrib>Colwill, Karen</creatorcontrib><creatorcontrib>Drews, Steven J</creatorcontrib><creatorcontrib>Gingras, Anne-Claude</creatorcontrib><creatorcontrib>Hinshaw, Deena</creatorcontrib><creatorcontrib>Jha, Prabhat</creatorcontrib><creatorcontrib>Kanji, Jamil N</creatorcontrib><creatorcontrib>Kirsh, Victoria A</creatorcontrib><creatorcontrib>Lang, Amanda L.S</creatorcontrib><creatorcontrib>Langlois, Marc-Andre</creatorcontrib><creatorcontrib>Lee, Stephen</creatorcontrib><creatorcontrib>Lewin, Antoine</creatorcontrib><creatorcontrib>O'Brien, Sheila F</creatorcontrib><creatorcontrib>Pambrun, Chantale</creatorcontrib><creatorcontrib>Skead, Kimberly</creatorcontrib><creatorcontrib>Stephens, David A</creatorcontrib><creatorcontrib>Stein, Derek R</creatorcontrib><creatorcontrib>Tipples, Graham</creatorcontrib><creatorcontrib>Van Caeseele, Paul G</creatorcontrib><creatorcontrib>Evans, Timothy G</creatorcontrib><creatorcontrib>Oxlade, Olivia</creatorcontrib><creatorcontrib>Mazer, Bruce D</creatorcontrib><creatorcontrib>Buckeridge, David L</creatorcontrib><collection>Gale In Context: Canada</collection><collection>Gale In Context: Science</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murphy, Tanya J</au><au>Swail, Hanna</au><au>Jain, Jaspreet</au><au>Anderson, Maureen</au><au>Awadalla, Philip</au><au>Behl, Lesley</au><au>Brown, Patrick E</au><au>Charlton, Carmen L</au><au>Colwill, Karen</au><au>Drews, Steven J</au><au>Gingras, Anne-Claude</au><au>Hinshaw, Deena</au><au>Jha, Prabhat</au><au>Kanji, Jamil N</au><au>Kirsh, Victoria A</au><au>Lang, Amanda L.S</au><au>Langlois, Marc-Andre</au><au>Lee, Stephen</au><au>Lewin, Antoine</au><au>O'Brien, Sheila F</au><au>Pambrun, Chantale</au><au>Skead, Kimberly</au><au>Stephens, David A</au><au>Stein, Derek R</au><au>Tipples, Graham</au><au>Van Caeseele, Paul G</au><au>Evans, Timothy G</au><au>Oxlade, Olivia</au><au>Mazer, Bruce D</au><au>Buckeridge, David L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><date>2023-08-14</date><risdate>2023</risdate><volume>195</volume><issue>31</issue><spage>E1030</spage><pages>E1030-</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><abstract>Interpretation: Data up to March 2023 indicate that most people in Canada had acquired antibodies against SARS-CoV-2 through natural infection and vaccination. However, given variations in population seropositivity by age and geography, the potential for waning antibody levels, and new variants that may escape immunity, public health policy and clinical decisions should be tailored to local patterns of population immunity.</abstract><pub>CMA Impact Inc</pub><doi>10.1503/cmaj.230949</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0820-3946 |
| ispartof | Canadian Medical Association journal (CMAJ), 2023-08, Vol.195 (31), p.E1030 |
| issn | 0820-3946 1488-2329 |
| language | eng |
| recordid | cdi_gale_infotracmisc_A760576387 |
| source | DOAJ Directory of Open Access Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Canada Epidemics Risk factors Statistics |
| title | The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020-2023 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A39%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20evolution%20of%20SARS-CoV-2%20seroprevalence%20in%20Canada:%20a%20time-series%20study,%202020-2023&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Murphy,%20Tanya%20J&rft.date=2023-08-14&rft.volume=195&rft.issue=31&rft.spage=E1030&rft.pages=E1030-&rft.issn=0820-3946&rft.eissn=1488-2329&rft_id=info:doi/10.1503/cmaj.230949&rft_dat=%3Cgale%3EA760576387%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A760576387&rfr_iscdi=true |